Works matching IS 10538569 AND DT 2019 AND VI 28 AND IP 4
Results: 22
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 422, doi. 10.1002/pds.4763
- By:
- Publication type:
- Article
Secret safety warnings on medicines: A case study of information access requests.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 551, doi. 10.1002/pds.4762
- By:
- Publication type:
- Article
Availability of drug at convenient stores is not associated with an increased incidence of their poisoning.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 536, doi. 10.1002/pds.4760
- By:
- Publication type:
- Article
Exposure to phthalate‐containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case‐control study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 528, doi. 10.1002/pds.4759
- By:
- Publication type:
- Article
Anticipating the effects of restricting high‐dose preparations of strong opioids in Australia: A population‐based analysis to inform the current policy debate.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 521, doi. 10.1002/pds.4755
- By:
- Publication type:
- Article
Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 515, doi. 10.1002/pds.4754
- By:
- Publication type:
- Article
Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 443, doi. 10.1002/pds.4752
- By:
- Publication type:
- Article
Does the use of incretin‐based medications increase the risk of cancer in patients with type‐2 diabetes mellitus?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 489, doi. 10.1002/pds.4746
- By:
- Publication type:
- Article
Proton‐pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high‐risk antibiotics users: A population‐based case‐crossover study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 479, doi. 10.1002/pds.4745
- By:
- Publication type:
- Article
Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 437, doi. 10.1002/pds.4740
- By:
- Publication type:
- Article
Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low‐incidence population: A nationwide study in Korea.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 507, doi. 10.1002/pds.4737
- By:
- Publication type:
- Article
Use and safety of disease‐modifying therapy in pregnant women with multiple sclerosis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 556, doi. 10.1002/pds.4735
- By:
- Publication type:
- Article
Use of dipeptidyl peptidase‐4 inhibitors and the risk of arthralgia: Population‐based cohort and nested case–control studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 500, doi. 10.1002/pds.4733
- By:
- Publication type:
- Article
Oseltamivir phosphate—Lifting the restriction on its use to treat teenagers with influenza in Japan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 434, doi. 10.1002/pds.4721
- By:
- Publication type:
- Article
A systematic review of methods for determining cross‐sectional active medications using pharmacy databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 403, doi. 10.1002/pds.4706
- By:
- Publication type:
- Article
Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population‐based case‐control study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 471, doi. 10.1002/pds.4702
- By:
- Publication type:
- Article
Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 439, doi. 10.1002/pds.4697
- By:
- Publication type:
- Article
Statin use and survival in patients with gastric cancer in two independent population‐based cohorts.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 460, doi. 10.1002/pds.4688
- By:
- Publication type:
- Article
A tailor‐made approach for causality assessment for ADR reports on drugs and vaccines.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 544, doi. 10.1002/pds.4637
- By:
- Publication type:
- Article
Prenatal exposure to non‐steroidal anti‐inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 452, doi. 10.1002/pds.4625
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 561, doi. 10.1002/pds.4596
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. N.PAG, doi. 10.1002/pds.4595
- Publication type:
- Article